Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus. - Wikidata - awgldk - TriplyDB

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.

http://www.wikidata.org/entity/Q33747762

about

Promising oncolytic agents for metastatic breast cancer treatment SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I Axl as a mediator of cellular growth and survival Growth, metastasis, and expression of CCL2 and CCL5 by murine mammary carcinomas are dependent upon Myd88.Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer Cancer stem cells in breast cancer.Molecular insights of Gas6/TAM in cancer development and therapy.Oncolytic bovine herpesvirus type 1 infects and kills breast tumor cells and breast cancer-initiating cells irrespective of tumor subtype.Mammary Stem Cells and Breast Cancer Stem Cells: Molecular Connections and Clinical Implications

P2860

Q26830620-22F50DD7-D0D6-4889-8789-3B58AEAB4C86 Q27307734-D7F96442-4DAE-49DB-A446-E1816CC132EC Q34619118-C3EDE170-AA27-4155-91E7-6DBEB4A91690 Q35629284-83F28206-1FB4-443B-81E3-1FA8EA761B7A Q36582785-CBC2513B-8FBF-4E2B-B57F-222288D459FD Q37111104-A0366164-940F-455B-A40D-BF513C729CC4 Q37129887-2AD0E703-C8CE-4F6E-B429-0A1A5DCEDD8F Q37745358-275477AE-97A1-4983-A6D8-387C86E09B7F Q39160342-A3A00821-36ED-48E7-85B4-3E9580403816 Q57112976-58D288EA-CBD4-4856-B275-8D6EF6F535CA

P2860

Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.

http://www.wikidata.org/entity/Q33747762

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@ast

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@en

type

label

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@ast

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@en

prefLabel

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@ast

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@en

P1433

Q33747762-310835F2-597C-4A7E-8519-6DE747E28173

P1476

Q33747762-CC5B1DBB-2BB0-4C23-93DF-6FD5E79A5D7C

P2093

Q33747762-80F5CEEF-F0D0-4D6D-B0A9-3FB09A1D8B0D

Q33747762-C7295F3E-A917-4030-9146-7D08FCF47EAD

Q33747762-CC2054C0-D3F3-4636-8BB0-F7EAC693D840

P2860

Q33747762-0156A51F-8FE0-443D-9023-279C5A0F73D7

Q33747762-04594A8A-8741-43FF-B6B5-7AB327E773BC

Q33747762-05735571-4994-477D-8A6D-E7869F46FC4D

Q33747762-08342F4A-6BF2-40E3-B1E0-061E8200BDBF

Q33747762-0DC986B0-2634-4D15-ABD0-4A7694F009A4

Q33747762-1B0DFE02-983E-4FE7-8A9B-7DA42FFAC3D0

Q33747762-1E7329CA-74C0-4B40-B546-723B2B472105

Q33747762-22208757-3E6B-4D9A-9544-90361A52CB95

Q33747762-24754AB9-6657-475C-9E83-7C2B6C58B6CF

Q33747762-395543E1-1441-4875-BF96-856B0FD24B11

P304

Q33747762-448A5E34-7B6C-425E-B6D1-0DB704F17E76

P31

Q33747762-0082EC2A-3BE0-46CE-BEE5-37126FD8EBED

P356

Q33747762-35C6FF24-A2D4-4289-936D-C67B6DB8E878

P407

Q33747762-E3F7DFE8-41B2-4641-A82E-166FC75BF749

P433

Q33747762-B5B9ED55-9C16-44B1-9455-A07C25256E25

P478

Q33747762-07B28FA1-4B7C-46B7-9CE2-BF4F173D5711

P50

Q33747762-0D5DDE27-5950-4F2B-B83E-242C5A5267DF

Q33747762-5FDAE250-ABFA-4763-A897-8C424A2F26BC

Q33747762-87F178E5-7EC2-424F-81C1-E4ADD942ADB0

Q33747762-8AD9C6FB-0C38-4B52-AD1F-076FD211FD95

Q33747762-CAE4D716-42F2-4D2A-B32D-B6402D017188

Q33747762-F22103C0-D289-4B42-967E-29D14367573A

P577

Q33747762-72068405-7A29-4D0B-9926-89DC6F8E62C6

P5875

Q33747762-124FBD5B-6513-4794-BD49-408F2955386B

P698

Q33747762-99DE1709-432E-4B59-9FA2-533EEC580D4C

P921

Q33747762-CD91F383-632B-4A40-B4A4-9721911D0368

Q33747762-F25B5400-264F-4CA5-9233-6A9AB2DFC370

P932

Q33747762-FE8BC1FB-B7BD-40FF-BA5B-AB8DBF604934

P356

JOURNAL.PONE.0013859

P1433

P1476

Defects in innate immunity ren ...... ssive to oncolytic adenovirus.

@en

P2093

Cristina Mirantes

http://www.w3.org/2001/XMLSchema#string

Pamela Osterlund

http://www.w3.org/2001/XMLSchema#string

Tiina Jahkola

http://www.w3.org/2001/XMLSchema#string

P2860

Direct suppression of Stat1 function during adenoviral infection

Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma

The epithelial-mesenchymal transition generates cells with properties of stem cells

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

Prospective identification of tumorigenic breast cancer cells

Identification of human brain tumour initiating cells

Tissue-specific promoters active in CD44+CD24-/low breast cancer cells

Stat3 as an oncogene

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

P304

e13859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0013859

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Akseli Hemminki

Vincenzo Cerullo

Sophie Escutenaire

P577

2010-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47795083

http://www.w3.org/2001/XMLSchema#string

P698

21079774

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2974645

http://www.w3.org/2001/XMLSchema#string